a href"https:www.fiercepharma.compharmaboehringer-ingelheim-offloads-shanghai-cdmo-local-antibody-developer" hreflang"en"Boehringer Ingelheim offloads Shanghai CDMO to local antibody developera

Boehringer Ingelheim is bidding adieu to its biologics contract manufacturing unit in China, inking a small-scale deal that gives local developer Raas Blood Products an established biologics production base for its lead antibody drug candidate.